IBO
AMEX
$0.45
Impact BioMedical Inc (IBO)
Impact BioMedical, Inc. is an innovative biotechnology company focused on developing groundbreaking therapeutics and technologies to address critical healthcare challenges. Utilizing advanced research methodologies, the firm aims to improve patient outcomes and overall quality of life. With a robust intellectual property portfolio and an emphasis on scientific rigor, Impact BioMedical is well-positioned for growth in the evolving healthcare market. Its extensive product pipeline and strategic collaborations offer attractive investment opportunities for institutional investors interested in the accelerating biopharmaceutical sector.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$50M
Free Cash Flow Yield
-3.34%
Beta (5Y)
-0.92
Price Chart
Valuation
Market Cap$50M
P/S1260.68
P/B4.33
Profitability
Total Revenue (TTM)$39K
Gross Profit (TTM)-$385K
EBITDA-$4.41M
Operating Margin-32700%
EPS-$0.11
Financial Health
Free Cash Flow Yield-3.34%
Growth & Risk
Beta (5Y)-0.92
Sharpe Ratio0.10